Axsome Therapeutics, Inc. (AXSM) Social Stream



Axsome Therapeutics, Inc. (AXSM): $31.65

0.14 (+0.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Axsome Therapeutics Inc (AXSM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AXSM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 12 $180 $34 $98.272 $35.11 179.9%
2021-12-17 11 $180 $34 $98.272 $35.11 179.9%
2021-12-20 11 $180 $26 $95.727 $35.11 172.65%
2022-03-02 11 $180 $26 $89.363 $35.11 154.52%
2022-03-07 11 $180 $31 $88.454 $35.11 151.93%

The Trend in the Analyst Price Target


Over the past 21 months, AXSM's average price target has gone down $73.55.

Over the past 48 weeks, AXSM's average upside potential has been 183.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 7 210 62 143.850 52.99 171.47%
2021-07-24 14 225 62 140.210 53.68 161.2%
2021-08-01 14 225 62 140.210 48.59 188.56%
2021-09-18 15 180 25 86.210 29.72 190.07%
2021-12-20 11 180 26 95.727 35.97 166.13%

AXSM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.45 9 0 1 0 0 11

The Trend in the Broker Recommendations


Over the past 151 days, AXSM's average broker recommendation rating improved by 0.42.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AXSM as an investment opportunity.

  • In the context of all US stocks, Axsome Therapeutics Inc's variance in analysts' estimates is lower than -391.62% of them.
  • AXSM has a higher upside potential (average analyst target price relative to current price) than 441.96% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, Axsome Therapeutics Inc's number of analysts covering the stock is greater than 432.79% of them.
  • In the context of Pharmaceutical Products stocks, Axsome Therapeutics Inc's average analyst price target is greater than 423.36% of them.

In the Pharmaceutical Products industry, AVIR, AUPH, and ATAI are the three stocks most similar to Axsome Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6485 seconds.